HOME >> MEDICINE >> NEWS
The plague as a weapon?

The possibility of bubonic plague and pneumonic plague being used as bioterrorism agents is discussed in an article published this week in The Lancet.

Professor Mike Prentice, of University College, Cork, Ireland, and Dr Lila Rahalison, of Institut Pasteur, Madagascar, did a comprehensive review of the genetic makeup of the plague, its transmission vectors, and potential use as a biological weapon. They also look at a number of historical outbreaks of the disease, including the Black Death.

Plague is caused by the bacterium Yersinia Pestis, which multiplies in the gut fleas which have fed on blood from infected aminals. This causes a blockage in the proventriculus the tube which connects the gut and the oesophagus of the flea. This blockage causes the flea to continually regurgitate and feed again, introducing Y. Pestis into the bloodstream of whatever it is biting rodent or human.

The onset of bubonic plague is sudden, and causes malaise, dizziness, high fever and swellings near the lymph nodes called "buboes", after two to six days incubation.

Patients who develop secondary plague pneumonia after fleabite can transmit pneumonic plague directly to others. This form of plague generally has a shorter incubation time (two to three days) and is characterised by sudden onset, high fever, pleuritic chest pain and a cough containing bloody sputum.

It is now possible to harness the ability of the plague to spread by respiratory droplets, and make aerosol-based weapons capable of causing widespread pneumonic plague outbreak. This and many other factors could combine to make Y. Pestis an attractive agent for bioterrorism its wide distribution, simple culture techniques, the high mortality rate of the associated pulmonary disease, availability of expert advice from former weapons scientists, or perhaps only the knowledge that many countries have investigated its use as a weapon.

Untreated bubonic plague has m
'"/>

Contact: Professor Mike Prentice
m.prentice@ucc.ie
353-872-679-701
Lancet
5-Apr-2007


Page: 1 2

Related medicine news :

1. Research has shed light on the computer frustrations that plague older adults
2. High risk of chronic health conditions plagues those with schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The plague weapon

(Date:5/21/2013)... The producers of Net Worth Business TV ... Canada. The area is famous for its natural beauty and ... is located an hour from Toronto and is easily accessible ... Kawartha Hills, home to several towns, villages and hamlets which ... Residents and visitors to this region will be able to ...
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales ... in Los Cabos, Mexico, Feb. 23-March 1, 2013, to help ... , The facility serves meals and provides a social outlet ... Mexico. , Platinum Vice President, Mike Muench, says that the ... history. , “Platinum got its start selling long-term care ...
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales & Service ... newest in digital recording technology, to the hands of ... anyone looking to get the most from technology professional ... is expected to have revolutionary options and impeccable design. ... features and highlights: ,      ...
(Date:5/21/2013)... By Steven Reinberg HealthDay Reporter , , MONDAY, ... behind the wheel while drowsy run a higher risk ... found that not catching up on missed sleep on ... an accident at night. "This is another challenge ... Dr. Flaura Winston, co-scientific director and founder of the ...
(Date:5/21/2013)... negative effects of poorly controlled asthma symptoms on ... has been confirmed in a new study. ... sleep and school absences are important indicators of ... first to explore the associations between asthma, sleep ... using both objective and subjective measures," said ...
Breaking Medicine News(10 mins):Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Asthma symptoms impair sleep quality and school performance in children 2
(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue:   ... Scenario for Medical Devices in the US ...   Changing Regulatory and Reimbursement ... Market   Summary ...
(Date:5/21/2013)... , May 21, 2013  AcelRx Pharmaceuticals, ... specialty pharmaceutical company focused on the development ... treatment of acute and breakthrough pain, today ... placebo-controlled Phase 3 study of its investigational ... (NanoTab System), the primary efficacy endpoint was ...
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , ... bidding procurement program for home medical equipment is ... North Carolina to lay off employees or ... quality of service and products received by Medicare beneficiaries, ... the defective and dangerous program, the Centers for ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
Cached News: